Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04983641 · ClinicalTrials.gov registry record · NA
Pre-visit Digital Messaging Improves Patient Reported Outcome Measure Participation Prior to the Orthopedic Ambulatory Visit
A NA study of Orthopedic Disorder, sponsored by Henry Ford Health System.
- Completed
- Registry status
- NA
- Development phase
- 291
- Enrollment target
- 1
- Study location
NCT04983641: Completed NA study of Orthopedic Disorder, sponsored by Henry Ford Health System.
NCT04983641 is a NA study of Orthopedic Disorder that has completed, run by Henry Ford Health System. The registered enrollment target is 291 participants, above the 106-participant average among 10 other Orthopedic Disorder trials with a reported enrollment target (175% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04983641, a NA study of Orthopedic Disorder, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 291 participants
- Enrollment target
- 1
- Study location
Study Summary
Patient-Reported Outcomes Measurement Information System (PROMIS) forms will be administered remotely to consecutive Orthopaedic patients presenting for new physician clinic visits. These patients will be sent either reminder e-mails, reminder digital patient portal ("MyChart") messages, or no reminder messages at all concerning PROMIS form completion at timepoints prior to their respective clinic visits and PROMIS form completion rates will consequently be assessed. The primary objective of this study is to develop an understanding of whether pre-visit reminder messages influence PROMIS form completion in Orthopaedic patients.
Primary Outcome
Investigators will assess whether reminder messages prior to clinic visit have an impact on both remote pre-visit and overall PROMIS form completion rates in orthopaedic patients. Patients completing a single assigned PROMIS form will be regarded as having PROMIS completion.
Conditions Studied
Interventions
- OTHER Pre-Visit Messages
Study Locations (1)
Michigan
- Henry Ford Health System - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 291 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2020-12-07 |
| Phase | NA |
What the finished NCT04983641 record still lists
NCT04983641 is an interventional study that assigns participants to a tested intervention. The registered 291 participants enrollment target is mid-sized for trials with a published cap, above the 106-participant average among 10 other Orthopedic Disorder trials with a reported enrollment target (175% higher).
The record links to 1 condition, with Orthopedic Disorder appearing as the primary indexed condition, and to 1 intervention - of which Pre-Visit Messages is the first listed.
NCT04983641 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT04983641 about?
NCT04983641 is a clinical study titled "Pre-visit Digital Messaging Improves Patient Reported Outcome Measure Participation Prior to the Orthopedic Ambulatory Visit". Patient-Reported Outcomes Measurement Information System (PROMIS) forms will be administered remotely to consecutive Orthopaedic patients presenting for new physician clinic visits. These patients will be sent either reminder e-mails, reminder digital patient portal ("MyChart") messages, or no remin...
What is the current status of trial NCT04983641?
This trial is currently completed. It is a NA study. The enrollment target is 291 participants. The study started on 2020-08-01. Estimated completion is 2020-12-07.
What conditions does trial NCT04983641 study?
This clinical trial studies the following conditions: Orthopedic Disorder.
What interventions are being tested in trial NCT04983641?
The interventions under investigation include: Pre-Visit Messages (OTHER).
Who is sponsoring clinical trial NCT04983641?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04983641 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Orthopedic Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04983641's enrollment target sits among peer trials
291 2nd of 10 the highest of 10 other Orthopedic Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Orthopedic Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Quadriceps Tendon Versus Bone Patellar Tendon Bone Autograft ACL Reconstruction RCT
RECRUITING · NA
-
Early Versus Delayed Rehabilitation After Reverse Total Shoulder Arthroplasty for Proximal Humerus Fracture
RECRUITING · NA
-
Web-based Mind-body Program to Improve Resilience Among Risky Substance Users With Persistent Upper Extremity Pain
RECRUITING · NA
-
Pre-operative Inspiratory Muscle Strength Training in Total Joint Surgery
RECRUITING · NA
-
An Imaging Framework for Clinically Testing New Treatments to Prevent Post-traumatic OA
RECRUITING · NA
-
The Impact of a mHealth Application on Outpatient Physical Therapy HEP Adherence and Outcomes: A RCT
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02074839 · 291 participants · Phase 1
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
- NCT03769766 · 291 participants · Phase 3
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance
- NCT06563479 · 291 participants · Phase 3
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer
- NCT04429542 · 292 participants · Phase 1
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI